D.E. Shaw & Co’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-45,992
| Closed | -$472K | – | 3403 |
|
2023
Q2 | $472K | Hold |
45,992
| – | – | ﹤0.01% | 2359 |
|
2023
Q1 | $465K | Hold |
45,992
| – | – | ﹤0.01% | 2539 |
|
2022
Q4 | $460K | Hold |
45,992
| – | – | ﹤0.01% | 2746 |
|
2022
Q3 | $446K | Hold |
45,992
| – | – | ﹤0.01% | 2927 |
|
2022
Q2 | $446K | Hold |
45,992
| – | – | ﹤0.01% | 3096 |
|
2022
Q1 | $448K | Buy |
45,992
+2,300
| +5% | +$22.4K | ﹤0.01% | 3267 |
|
2021
Q4 | $429K | Buy |
43,692
+23,916
| +121% | +$235K | ﹤0.01% | 3156 |
|
2021
Q3 | $194K | Buy |
+19,776
| New | +$194K | ﹤0.01% | 3257 |
|